tesaglitazar associated_with hyperglycemia
Evidence from:
primary |
all sources
Evidence (1 sources)
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
Tesaglitazar treatment did not correct ... the associated moderate hyperglycemia of the obese Zucker rat.
confidence: 0.95